Elevance Health ($ELV) Insider Trading & Smart Money Activity
Elevance Health, Inc. ($ELV) has 2 insider trades, 1 congress trade, 20 13F position changes and 2 analyst ratings on file. In the last 12 months on the open market, no insider bought and 2 insiders sold ($209.43K), net -$209.43K.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 2
- Net insider $ (12 mo)
- -$209.43K
- Congress trades (12 mo)
- 1
- 13F moves on file
- 20
- Analyst ratings on file
- 2
ELV insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 1 / 0 | 0 / 0 |
| Q2 2026 | 0 | 2 · $209.43K | 0 / 0 | 16 / 3 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 1 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All ELV insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 13F | DAVENPORT | Reduced | -57.51K sh | $149.99M | — | ||||||
| Analyst | Guggenheim | Reiterates to Buy | PT $460 | Read | |||||||
| Analyst | Barclays | Reiterates to Overweight | PT $469 | +5.9% | — | ||||||
| Insider | Ronald PenczekCAO & Controller | Sell (Open-market sale) | 369 sh | $148.77K | -2.3% | +5.2% | — | ||||
| Insider | Dixon Robert JR | Sell (Open-market sale) | 151 sh | $60.67K | -2.7% | +6.5% | — | ||||
| 13F | Hotchkis & Wiley Capital Management | Added | +140.41K sh | $874.83M | +0.5% | +2.8% | — | ||||
| 13F | Hotchkis & Wiley Capital Management | Added | +140.41K sh | $846.69M | +0.5% | +2.8% | — | ||||
| 13F | Eagle Capital Management | Added | +44.56K sh | $618.17M | +0.5% | +2.8% | Read | ||||
| 13F | Eagle Capital Management | Added | +44.56K sh | $598.29M | +0.5% | +2.8% | — | ||||
| 13F | Brown Advisory | Added | +40.66K sh | $215.80M | +0.5% | +2.8% | — | ||||
| 13F | Brown Advisory | Added | +40.66K sh | $208.86M | +0.5% | +2.8% | — | ||||
| 13F | Sanders Capital | Added | +143.44K sh | $2.35B | -1.7% | +1.7% | — | ||||
| 13F | Sanders Capital | Added | +143.44K sh | $2.28B | -1.7% | +1.7% | — | ||||
| 13F | Massachusetts Financial Services | Reduced | -124.73K sh | $892.62M | -1.7% | +1.7% | — | ||||
| 13F | Massachusetts Financial Services | Reduced | -124.73K sh | $863.91M | -1.7% | +1.7% | — | ||||
| 13F | Bank of Nova Scotia | Added | +104.21K sh | $93.55M | -1.7% | +1.7% | Read | ||||
| 13F | Artisan Partners Limited Partnership | Added | +94.42K sh | $2.05B | -0.9% | +1.5% | — | ||||
| 13F | Artisan Partners Limited Partnership | Added | +94.42K sh | $1.98B | -0.9% | +1.5% | — | ||||
| 13F | First Eagle Investment Management | Added | +109.42K sh | $1.65B | +2.3% | +1.9% | — | ||||
| 13F | First Eagle Investment Management | Added | +109.42K sh | $1.60B | +2.3% | +1.9% | — | ||||
| 13F | Cibc Bancorp USA | Added | +431.33K sh | $184.59M | +2.3% | +1.9% | — | ||||
| 13F | Cibc Bancorp USA | Added | +431.33K sh | $178.65M | +2.3% | +1.9% | — | ||||
| 13F | Onedigital Investment Advisors | Added | +1.12K sh | $2.76M | +3.9% | +10.6% | — | ||||
| 13F | Hb Wealth Management | Reduced | -4.57K sh | $8.01M | +4.4% | +9.9% | — | ||||
| Congress | Alan Armstrong | Purchase | $1,001 - $15,000 | +5.7% | +24.4% | +39.5% | — |
1W / 1M / 6M = how ELV moved from the trade or filing date.
Insider trading in ELV: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Ronald Penczek | CAO & Controller | 1 | -$148.77K | Jun 12, 2026 | |
| Dixon Robert JR | 1 | -$60.67K | Jun 11, 2026 |
Members of Congress trading ELV
Institutions moving ELV (13F)
Analyst ratings on ELV
| Date | Firm | Action | Rating | Price target | 1W | 1M | 6M | Story |
|---|---|---|---|---|---|---|---|---|
| Guggenheim | Reiterates | Buy | $455 → $460 | Read | ||||
| Barclays | Reiterates | Overweight | $457 → $469 | +5.9% | — |
Frequently asked questions
Are ELV insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 2 insiders made 2 open-market sales worth $209.43K, a net -$209.43K.
What is the latest insider trade in ELV?
Ronald Penczek, CAO & Controller filed a sell (open-market sale) of 369 sh worth $148.77K on Jun 12, 2026.
Which members of Congress traded ELV?
1 disclosed trade by Alan Armstrong. The latest was on Mar 27, 2026.
Which institutions changed their ELV positions?
Recent 13F filers moving the stock include Hotchkis & Wiley Capital Management, Eagle Capital Management, Brown Advisory, Sanders Capital and Massachusetts Financial Services.
Other healthcare plans stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.